Haemostatic drug less effective than originally predicted

The use of recombinant activated factor 7 (rFVIIa) - a drug used to treat bleeding in haemophiliacs - in patients without haemophilia is not recommended because of the potential for adverse events, found a study published in CMAJ (Canadian Medical Association Journal)...

Read the whole article on

More from